# Replication of the Heads Up Atopic Dermatitis Trial With Registry Data

> **NCT06937788** · — · RECRUITING · sponsor: **Technische Universität Dresden** · enrollment: 240 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Upadacitinib
- **BIOLOGICAL:** Dupilumab

## Key facts

- **NCT ID:** NCT06937788
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-02
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06937788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06937788, "Replication of the Heads Up Atopic Dermatitis Trial With Registry Data". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06937788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*